Group One Trading’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50
Closed -$247 8684
2025
Q1
$247 Buy
+50
New +$159 ﹤0.01% 7355
2024
Q2
Sell
-12,564
Closed -$56.6K 7514
2024
Q1
$67.2K Buy
12,564
+3,429
+38% +$16.1K ﹤0.01% 4463
2023
Q4
$39K Buy
9,135
+7,800
+584% +$24K ﹤0.01% 5250
2023
Q3
$5.23K Buy
+1,335
New +$8.76K ﹤0.01% 6682
2022
Q2
Sell
-4,049
Closed -$69K 8539
2022
Q1
$69K Sell
4,049
-51,552
-93% -$874K ﹤0.01% 5852
2021
Q4
$1.43M Buy
+55,601
New +$1.73M ﹤0.01% 2967

Other funds holding TSVT

Group One Trading's TSVT Position: Q2 2025 in Review

Group One Trading sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 50 shares — an estimated $247 sold.

Group One Trading first reported a position in TSVT in Q4 2021 and held it in 6 quarters. The position peaked at $1.43M in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Group One Trading reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 50 2seventy bio shares in Q2 2025, an estimated $247.
  • Group One Trading first reported a position in 2seventy bio in Q4 2021 and held it in 6 quarters.
  • Group One Trading's 2seventy bio position peaked at $1.43M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.